Gene: CCDC92B
Official Full Name: coiled-coil domain containing 92Bprovided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18976 | CCDC92B Knockout cell line (HeLa) | Human | CCDC92B | 1:3~1:6 | Negative | Online Inquiry |
KO18977 | CCDC92B Knockout cell line (HCT 116) | Human | CCDC92B | 1:2~1:4 | Negative | Online Inquiry |
KO18978 | CCDC92B Knockout cell line (HEK293) | Human | CCDC92B | 1:3~1:6 | Negative | Online Inquiry |
KO18979 | CCDC92B Knockout cell line (A549) | Human | CCDC92B | 1:3~1:4 | Negative | Online Inquiry |
CCDC92B Gene Knockout Cell Lines are specialized cellular models designed for the comprehensive study of the CCDC92B gene's function and its role in various biological processes. These knockout cell lines are engineered through advanced CRISPR/Cas9 gene-editing technology, which ensures precise deletion of the CCDC92B gene, allowing researchers to investigate the phenotypic changes and downstream effects associated with this gene's loss-of-function.
Functionally, CCDC92B is implicated in multiple cellular pathways, particularly those related to cell division and cytoskeletal organization. Knockout models allow for the detailed exploration of these pathways, providing insights into how alterations in CCDC92B expression may contribute to diseases such as cancer and neurodegenerative disorders. Researchers can utilize these models to conduct assays related to cell growth, migration, and response to therapeutic agents, significantly enhancing the understanding of disease mechanisms and potential treatment strategies.
The scientific importance of CCDC92B Gene Knockout Cell Lines extends to both research and clinical settings. In academia, these models serve as fundamental tools for elucidating gene function and conducting genetic screenings. In clinical research, they can aid in testing the efficacy of drugs, ultimately contributing to more personalized medicine approaches.
What sets CCDC92B Gene Knockout Cell Lines apart from alternatives is their specificity and reliability. Unlike traditional knockdown approaches that may only reduce gene expression, our knockout lines provide a complete loss-of-function model, yielding clearer and more interpretable results. Furthermore, our cell lines come with extensive documentation and support, ensuring a streamlined process for researchers.
Ultimately, the value of CCDC92B Gene Knockout Cell Lines lies in their ability to accelerate scientific discovery and enhance translational research efforts. With our company’s commitment to cutting-edge genetic tools and extensive expertise in the field of molecular biology, we are dedicated to supporting researchers and clinicians in their quest to unlock new therapeutic avenues and advance understanding of gene function.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.